We use cookies to provide some features and experiences in QOSHE

More information  .  Close
Aa Aa Aa
- A +

Investors poured nearly $8 billion dollars into synthetic biology last year. This company is leading the field.

1 0 0

One of the keys to combating COVID-19—and its variants—is the ability to study its genome and conduct tests on it at scale. And key to this effort is synthetic DNA.

Founded in 2013, Twist Bioscience is a pioneer in this field. It has developed a method of affordably writing DNA on silicon chips, which can be used by researchers in therapeutics and precision medicine, agricultural, and biomaterials.

When COVID-19 hit last year, Twist adapted its technology to develop a synthetic control version of the virus, which has been used by numerous labs to create and validate tests for COVID-19 and its variants. This earned Twist a place on Fast Company’s list of the 10 Most Innovative Biotech Companies of 2021. But the applications of Twist’s DNA go far beyond COVID-19, from fighting cancer to storing episodes of your favorite Netflix show.

On this week’s Most Innovative Companies........

© Fast Company

Get it on Google Play